Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AMGEN INC.

(AMGN)
  Report
Delayed Nasdaq  -  04:00 2022-12-07 pm EST
285.76 USD   +0.87%
12/07Amgen : When It Comes to Biosimilar Manufacturing, Heritage and Expertise Matter
PU
12/07Amgen : Investor Presentation December 2022
PU
12/07Amgen : Alliances Help Connect Patients with Lung Cancer to Precision Medicine Treatments
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société AMGEN INC.
12/07Amgen : When It Comes to Biosimilar Manufacturing, Heritage and Expertise Matter
PU
12/07Amgen : Investor Presentation December 2022
PU
12/07Amgen : Alliances Help Connect Patients with Lung Cancer to Precision Medicine Treatments
PU
12/05Juno Therapeutics Requests That The Supreme Court Wait To Make A Decision On Its Writte..
AQ
12/05Amgen : WCIRDC Presentation
PU
12/02Amgen : Announcement for the purposes of rule 2.12 of the irish takeover panel act
PU
12/02Amgen : Regulation FD Presentation - Form 8-K
PU
12/02Amgen Inc : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
12/02Amgen presents new amg 133 phase 1 clinical data at wcirdc 2022
AQ
11/28Amgen to webcast investor call at wcirdc 2022
PR
11/24U.S. Supreme Court To Decide On Enablement Standard For Biotech Antibody Patents In Amg..
AQ
11/23Amgen announces webcast of 2022 evercore isi healthcare conference
PR
11/17USSC Agrees To Reconsider Amgen Inc. V Sanofi On Enablement Of Antibody Genus Claims
AQ
11/14Supreme Court To Consider Enablement Requirement
AQ
11/11Amgen v. Sanofi Case On Enablement Of Antibody Genus Claims Will Be Heard At The Suprem..
AQ
11/10Amgen : Latest Acquisition Puts a Spotlight on Rare Autoimmune Disease
PU
11/09Supreme Court To Address What It Means To Have An Enabling Disclosure
AQ
11/07Amgen announces webcast of 2022 credit suisse global healthcare conference
AQ
11/04Amgen announces webcast of 2022 credit suisse global healthcare conference
PR
11/04AMGEN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
11/03Amgen : Q3 Earnings Snapshot
AQ
10/31Amgen announces webcast of 2022 third quarter financial results
PR
10/28Amgen announces 2022 fourth quarter dividend
PR
10/27Amgen : Staff Around the World Volunteer for International Coastal Cleanup
PU
10/26Amgen : Five Takeaways from Amgen's Roundtable on Climate Change and Human Health
PU
10/20Amgen Inc : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
10/17Amgen Releases 2022 Biosimilar Trends Report
AQ
10/13Amgen : Recognizing National Disability Employment Awareness Month
PU
10/12Amgen : Follow the Data
PU
10/12BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1/2 Trial and US FD..
AQ
10/12Amgen's annual trends report finds competition created by biosimilars contributed $21 b..
PR
10/06Amgen : Officially Opens New State-Of-The-Art R&D Site In San Francisco
PU
10/06Amgen opens new state-of-the-art research and development laboratory site in san franci..
PR
09/16Amgen : Is Ready to Meet Growing Demand for Innovative Medicines, Says Bradway in Bloomber..
PU
09/13Asthma Peak Week : What You Need to Know About Indoor Air Pollution
PU
09/12Amgen announces webcast of 2022 bank of america merrill lynch global healthcare confere..
PR
09/12Lumakras® (sotorasib) combined with vectibix® (panitumumab) shows confirmed 30% objecti..
PR
09/09Amgen announces positive new data at eadv 2022 for otezla
AQ
09/08Amgen announces webcast of 2022 morgan stanley global healthcare conference
PR
09/08Amgen announces positive new data at eadv 2022 for otezla® (apremilast)
PR
09/07Amgen to webcast investor call at esmo 2022
PR
09/02Amgen announces webcast of 2022 wells fargo healthcare conference
PR
09/02Amgen announces webcast of 2022 citi global healthcare conference
PR
08/31Amgen announces topline data from lumakras phase 3 trial in non-small cell lung cancer
AQ
08/30Amgen to present new, positive clinical and real-world data across inflammation portfol..
PR
08/25Amgen : How Genetic Validation Helped Innovate Medicine for Patients with High Cholesterol
PU
08/23Amgen announces positive top-line results from phase 3 study of abp 959, biosimilar can..
PR
08/22Amgen to present new data at esc congress 2022 highlighting up to 8.5 years of repatha®..
PR
08/18Amgen Inc : Entry into a Material Definitive Agreement, Financial Statements and Exhibits ..
AQ
08/16Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
08/16Amgen Chronicles : Fresh Water and Fresher Ideas About Sustainability in Puerto Rico
PU
08/12Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
08/08Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
08/05Amgen reports second quarter 2022 financial results
AQ
08/05AMGEN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
08/04Amgen : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS - Form 8-K
PU
08/04Amgen : Q2 Earnings Snapshot
AQ
08/04Amgen : TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH - Form 8-K
PU
08/04Amgen Inc : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia..
AQ
08/03Amgen : APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS - Form 8-K
PU
08/03Amgen Inc : Change in Directors or Principal Officers, Financial Statements and Exhibits (..
AQ
08/03Amgen appoints michael v. drake to board of directors
PR
08/03Amgen announces 2022 third quarter dividend
PR
08/02Amgen to webcast investor meeting at wclc 2022
PR
08/01Amgen announces webcast of 2022 second quarter financial results
PR
07/19Amgen : Amid "The Great Resignation" Why Some Amgen Employees Stayed
PU
07/07Amgen Releases Preview Of 2022 Trends In Biosimilars Report
AQ
06/10Amgen announces webcast of goldman sachs 43rd annual healthcare conference
PR
06/08Behind One Biotech's Water Conservat : Saving Every Drop
PU
06/07Amgen - FDA APPROVES RIABNI (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN (RITUXIMAB), FOR ..
AQ
06/06New Bpcia Complaint : Genentech Files Suit Against Tanvex Regarding Its Proposed Herceptin..
AQ
06/06FDA APPROVES RIABNI™ (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN® (RITUXIMAB), FOR ..
PR
06/03Amgen announces webcast of 2022 jefferies healthcare conference
PR
06/03Regeneron Files Antitrust Lawsuit Accusing Amgen Of Engaging In A Persistent Exclusiona..
AQ
06/01Amgen : Statement on Russia/Ukraine
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on AMGEN INC.